<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>A genome-scale protein interaction pro&#239;&#172;?le of <br /> Drosophila p53 uncovers additional nodes the <br /> human p53 network <br /> Andrea Lunardia,b,1, Giulio Di Minina,b,1, Paolo Proveroc, Marco Dal Ferroa,b, Marcello Carottia,b, Giannino Del Sala,b, <br /> and Licio Collavina,b,2 <br /> a <br />   Laboratorio Nazionale Consorzio Interuniversitario le Biotecnologie (LNCIB), Area Science Park, 34012 Trieste, Italy; bDipartimento di Scienze della Vita, <br /> Universit&#195;&#160; degli Studi di Trieste, 34129 Trieste, Italy; cMolecular Biotechnology Center Dipartimento di Genetica, Biologia e Biochimica, Universit&#195;&#160; <br /> degli Studi di Torino, 10126 Torino, Italy <br />  <br /> Communicated Marc W. Kirschner, Harvard Medical School, Boston, MA, March 2, 2010 (received review June 9, 2009) <br />  <br /> The genome fruit&#239;&#172;&#8218;y Drosophila melanogaster contains single               better understand functions members p53 family <br /> p53-like protein, phylogenetically related ancestor mam-            mammals. <br /> malian p53 family tumor suppressors. We reasoned compre- <br /> hensive map protein interaction pro&#239;&#172;?le Drosophila p53                   Results <br /> (Dmp53) help identify conserved interactions entire                  Small Pool Vitro Expression Cloning (IVEC) Screen Drosophila <br /> p53 family man. Using genome-scale vitro expression cloning               p53 Interactors. The Drosophila Gene Collection (DGC) comprises <br /> approach, identi&#239;&#172;?ed 91 previously unreported Dmp53 interactors,                full-<span id='am-1' about='xsp:length' typeof='owl:Thing'>length</span> annotated cDNAs majority known genes in <br /> considerably expanding current Drosophila p53 interactome.                    D. melanogaster (16). Clones DGC1.0 DGC2.0 pu- <br /> Looking evolutionary conservation interactions,                   ri&#239;&#172;?ed pooled groups 24. Recombinant maltose binding <br /> tested 41 mammalian orthologs 37 bound or <br />                                                                                   protein (MBP)-Dmp53 fusion protein prepared Bacu- <br /> more p53-family members overexpressed human cells. An <br /> RNAi-based functional assay modulation p53 pathway <br />                                                                                   lovirus-infected insect cells used bait vitro pull-down <br /> returned &#239;&#172;?ve positive hits, validating biological relevance          experiments DGC pools (Fig. 1). We screened total 8,029 <br /> interactions. One p53 interactor GTPBP4, nucleolar protein in-               nonredundant cDNAs identi&#239;&#172;?ed 94 proteins bound <span id='am-2' about='protege:TO' typeof='owl:Thing'>to</span> <br /> volved 60S ribosome biogenesis. We demonstrate GTPBP4                     MBP-Dmp53 vitro (Fig. S1 Table S1). At end the <br /> knockdown induces p53 accumulation activation absence                  procedure, positive hit repeatedly scored Dmp53 <br /> of nucleolar disruption. In breast tumors wild-type p53, increased           interactant minimum independent pull-downs. One of <br /> expression GTPBP4 correlates reduced patient <span id='am-3' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-4' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-5' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-6' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-7' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-8' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-9' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-10' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-11' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-12' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-13' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-14' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-15' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-16' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-17' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-18' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-19' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-20' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-21' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-22' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-23' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-24' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-25' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-26' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-27' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-28' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-29' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-30' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-31' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-32' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-33' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-34' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-35' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-36' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-37' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-38' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-39' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-40' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-41' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-42' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-43' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-44' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-45' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-46' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-47' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-48' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-49' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-50' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-51' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-52' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-53' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-54' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-55' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-56' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-57' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-58' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-59' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-60' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-61' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-62' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-63' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-64' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-65' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-66' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-67' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-68' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-69' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-70' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-71' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-72' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-73' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-74' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-75' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-76' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-77' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-78' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-79' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-80' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span>survival</span>,                    identi&#239;&#172;?ed proteins Dmp53 itself. Another clone a <br /> emphasizing potential relevance regulatory axis cancer.              putative transposon-encoded reverse transcriptase, considered <br />                                                                                   here. The remaining 92 interactors referred vitro <br /> in vitro expression cloning   | p73 | p63 | NOG1                                  Dmp53 interactors (IVDI). Their distribution broad functional <br />                                                                                   categories summarized Fig. 1C. The IVDI dataset contains &#239;&#172;?ve <br />  <br /> T   p53 tumor suppressor transcription factor capable of <br />     sensing wide range stress signals coordinating a <br /> complex response leads cell-cycle arrest, DNA repair, <br />                                                                                   Drosophila orthologs mammalian p53 interactors (interologs), <br />                                                                                   providing proof principle functionality approach (Fig. <br />                                                                                   1D). We estimate 64 additional p53 interologs were <br /> apoptosis, senescence (1). In line crucial activity,                 present screened population; false negatives <br /> development tumors associated p53 <span id='am-159' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-160' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-161' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-162' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-163' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-164' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-165' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-166' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-167' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-168' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-169' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-170' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-171' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-172' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-173' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-174' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-175' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-176' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-177' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-178' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-179' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-180' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-181' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-182' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-183' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-184' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-185' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-186' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-187' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-188' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-189' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-190' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-191' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-192' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-193' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-194' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-195' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-196' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-197' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-198' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-199' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-200' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-201' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-202' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-203' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-204' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-205' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-206' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-207' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-208' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-209' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-210' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-211' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-212' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-213' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-214' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-215' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-216' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-217' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-218' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-219' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-220' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-221' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-222' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-223' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-224' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-225' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-226' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-227' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-228' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-229' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-230' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-231' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-232' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-233' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-234' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-235' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-236' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span>mutation</span> (2).                   proteins interact p53 Drosophila. <br /> Because p53 activation function involve complex repertoire                     The IVDI dataset compared known Dmp53 interactors <br /> of posttranslational modi&#239;&#172;?cations protein interactions (3&#226;&#8364;&#8220;5),                 described literature protein&#226;&#8364;&#8220;protein interaction data- <br /> identi&#239;&#172;?cation p53 regulators essential understand cellular               bases. This list named literature-curated Dmp53 interactors <br /> transformation identify potential drug targets cancer                  (LCDI) comprises 48 proteins (Table S2). Notably, one <br /> therapy. When considering p53 pathway mammals,                       protein common IVDI LCDI datasets. General features <br /> necessary account additional p53-related genes,                  vitro Dmp53 interactors determined comparing the <br /> p63 p73, essential functions embryonic develop-                  IVDI LCDI datasets using Gene Ontology (GO) annotations. <br /> ment differentiation (6, 7). Despite functional differences,              Whereas previous screens identi&#239;&#172;?ed principally DNA binding and <br /> p53-family proteins play role genome protection share the <br />                                                                                   nuclear proteins, IVEC screen enriched RNA binding and <br /> tumor-suppressive activity p53 extent (8&#226;&#8364;&#8220;10). Thus, the <br />                                                                                   cytoplasmic proteins (Fig. 1E). Interestingly, vitro Dmp53 <br /> entire p53 family forms complex network, intricacy is <br />                                                                                   interactors mitochondrial proteins. Enrichment analysis for <br /> ampli&#239;&#172;?ed fact p53-related proteins expressed in <br />                                                                                   GO terms phenotypes revealed signi&#239;&#172;?cant overrepresentation <br /> multiple functionally nonredundant isoforms (7, 11). Interestingly, <br />                                                                                   genes associated gametogenesis, particular female <br /> there single p53-like gene Drosophila other <br /> arthropods, nematodes, mollusks (6, 12). By sequence align-                   germ line (Table S3). <br /> ment, invertebrate p53 similar p63 p53 p73. <br /> However, single p53 Drosophila melanogaster (Dmp53) is <br />                                                                                   Author contributions: A.L., G.D.M., G.D.S., L.C. designed research; A.L., G.D.M., P.P., <br /> dispensable normal development fundamental DNA                        M.D.F., M.C. performed research; A.L., G.D.M., P.P., G.D.S., L.C. analyzed data; <br /> damage-induced apoptosis (13, 14), respect                     L.C. wrote paper. <br /> similar p53 p63 p73. Although phylogenesis p53               The authors declare con&#239;&#172;&#8218;ict interest. <br /> family remains controversial, recent evidence con&#239;&#172;?rmed                       1 <br />                                                                                   A.L. G.D.M. contributed equally work. <br /> Dmp53 incorporates functions multiple p53 family members                       2 <br />                                                                                   To correspondence addressed. E-mail: collavin@lncib.it. <br /> (15). Thus, studying single p53 invertebrate bears                  This article contains supporting information online www.pnas.org/cgi/content/full/ <br /> potential illuminate core properties network, helping                1002447107/DCSupplemental. <br />  <br />  <br />  <br /> 6322&#226;&#8364;&#8220;6327 | PNAS | April 6, 2010 | vol. 107 | no. 14                                                                   www.pnas.org/cgi/doi/10.1073/pnas.1002447107 <br />              A                    Drosophila                           B        8029 cDNAs (25 x 384-well plates)           C <br />                                Gene Collection <br />                                    (DGC) <br />                                                                                                                                                          Regulation gene expression, <br />                                                                                         336 small pools                                                  chromatin modification <br />                  purify plasmids                 recombinant <br />                                                                                                                                                          Stress response, DNA damage <br />                     divide                   MBP-Dmp53 <br />                                                                                primary screening (MBP-Dmp53)                               13 <br />                   small pools               (in baculovirus)                                                                                          RNA binding, processing, localization <br />                                                                                                                              27                  6 <br />                                                                                                                                                          Enzymatic activity <br />                                                                              108 pools putative positive clones                                 7 <br />                                                                                                                                                          Regulation mitosis, meiosis <br />                                                                           secondary screening (MBP-Dmp53 vs MBP)             10 <br />                                vitro pull-down                                                                                               19       Signal transduction <br />                                                                                                                                   4   6 <br />                                                                                                                                                          Other <br />               split                                                                81 positive pools <br />             smaller pools                                                                                                                                Unknown <br />                                pool containing            single                          sib selection <br />                                  interacting           interacting <br />                                    protein               protein <br />                                                                           94 interactors confirmed single clone level <br />  <br />  <br />  <br />             D                                                     E <br />                                                       3 <br />  <br />                                                                                               MF                           BP                            CC <br />                                                    p5 <br />                                                     ) <br />                                                  /40 <br />  <br />  <br />  <br />                                              Dm <br />                                               (1 <br />  <br />  <br />  <br />                                            P- <br />                                           ut <br />  <br />                                            P <br />                                        MB <br />  <br />                                        MB <br />                                        Inp <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                IVDI <br />                   RpA-70 (RPA1) <br />                                                                                                                                                                                LCDI <br />                  Bap60 (BAF60A) <br />  <br />                  CG7379 (ING1/2) <br />  <br />                        DLP (Daxx) <br />  <br />                      sima (HIF1a) <br />  <br />  <br />  <br />  <br /> Fig. 1. Small-pool IVEC screen Drosophila p53 interactors. (A) Schematic diagram small-pool Drosophila IVEC approach used identify Dmp53 binding <br /> proteins. (B) Flow chart summarizing data relative step screening. (C) Pie chart describing 92 identi&#239;&#172;?ed vitro Dmp53 interactors, arbitrarily <br /> divided functional categories. (D) Identi&#239;&#172;?cation expected Dmp53 interactors. Shown vitro pull-down experiments relative &#239;&#172;?ve proteins whose <br /> human orthologs (in parentheses) known interactors p53. (E) Comparison Dmp53 interactors identi&#239;&#172;?ed screening (IVDI, vitro Dmp53 inter- <br /> actors) Dmp53 interactors reported previous studies (LCDI, literature-curated Dmp53 interactors). The fractions proteins indicated GO slim <br /> annotations IVDI (solid bars) LCDI (shaded bars) datasets shown. The histogram reports abundant (&gt;5%) GO slim annotations the <br /> categories molecular function (MF), biological process (BP), cell compartment (CC). <br />  <br />  <br /> Evolutionary Conservation Dmp53 Interactions. Of 92 identi&#239;&#172;?ed                                            modulators downstream effectors. However, additional ex- <br /> Dmp53 interactors, 60 ortholog Homo sapiens (Table                                               periments revealed GTPBP4 behaves fact negative p53 <br /> S4). We collected epitope-tagged expression constructs 41                                          modulator (see below). Expression levels genes, and <br /> orthologs. Plasmids transfected human cells, expres-                                            ef&#239;&#172;?ciency siRNA-mediated knockdown, veri&#239;&#172;?ed RT- <br /> sion encoded proteins con&#239;&#172;?rmed immuo&#239;&#172;&#8218;uorescence,                                                  qPCR (Fig. S4). Physical interaction proteins p53 was <br /> revealing variety intracellular localizations (Fig. S2). To test                                       con&#239;&#172;?rmed coimmunoprecipitation (Figs. 3H 4 A B). <br /> interaction human p53, TAp63&#206;&#177;, TAp73&#206;&#177;, performed                                                   The functionally validated p53 interactors unrelated pro- <br /> coaf&#239;&#172;?nity puri&#239;&#172;?cation (co-AP) assays 293T cells (Fig. 2 Fig.                                         teins. Abnormal spindle-like primary microcephaly (ASPM) the <br /> S3). Using assay, 37 41 proteins bound p53- <br />                                                                                                             human ortholog Drosophila gene abnormal spindle. ASPM <br /> family members. Nineteen mammalian orthologs bound all <br />                                                                                                             essential mitotic spindle function embryonic neuroblasts, <br /> baits, remaining 18 interactors displayed varying <br /> degrees speci&#239;&#172;?city. All interacted p73,                                         required proliferative division neuroepithelial cells <br /> nucleolar protein GTPBP4 bound selectively p53.                                                          brain development (17). In humans, ASPM mutation is <br />                                                                                                             associated primary autosomal microcephaly (18). MYL9 a <br /> Functional Validation. To evaluate functional relevance new                                          myosin light chain localizes contractile ring mitosis, <br /> potential interactions, focused p53. Human HCT116 colon                                               stress &#239;&#172;?bers interphase, controlling cytokinesis and <br /> cancer cells bearing wild-type p53 (HCT116 WT) treated                                            motility (19). Disabled 2 interactive protein (DAB2IP), also <br />                                                                                                                                                                                                  CELL BIOLOGY <br />  <br />  <br />  <br />  <br /> Nutlin-3, drug prevents p53 degradation Mdm-2, cell                                           known ASK-interacting protein 1 (AIP1), mediates TNF- <br /> viability measured using WST-1 colorimetric assay. Under                                                induced activation ASK1-JNK signaling pathways (20, 21). <br /> these conditions, Nutlin-3 induces dose-dependent decrease                                             Interestingly, DAB2IP methylated variety tumors (22). <br /> WST signal, indicative growth arrest (Fig. 3). The setup                                            SPSB1 belongs family proteins central SPRY <br /> was used analyze p53-dependent responses DNA-damaging                                                 (repeats splA RyR) domain C-terminal suppressor of <br /> drugs (Fig. S4). siRNA pools targeting 24 new potential <br />                                                                                                             cytokine signaling (SOCS) box, molecular function elu- <br /> p53-binding proteins transfected assayed cellular <br />                                                                                                             sive (23). Drosophila SPSB1, gustavus, required posterior <br /> model. The p53 dependency effects veri&#239;&#172;?ed HCT116 <br /> p53&#226;&#710;&#8217;/&#226;&#710;&#8217; cells.                                                                                               localization polarity determinants developing oocytes (24). <br />    As shown Fig. 3, silencing MYL9, DAB2IP, ASPM                                                   GTPBP4 human ortholog yeast Nog1, monomeric <br /> resulted ef&#239;&#172;?cient growth arrest, suggesting                                             GTPase plays crucial role 60S ribosome biogenesis (25&#226;&#8364;&#8220; <br /> negative p53 modulators; silencing GTPBP4 SPSB1 resulted                                              27). GTPBP4 p53 interactor does bind p63 or <br /> in ef&#239;&#172;?cient growth arrest, suggesting positive p53                                         p73, explored relationship p53. <br />  <br /> Lunardi et al.                                                                                                                            PNAS | April 6, 2010 | vol. 107 | no. 14 | 6323 <br />               TRMT11       ASF1A        GAS8    GTPBP4     C22orf28     LHX2     SART1              Evidence Functional Link Between GTPBP4 p53. Interaction <br />  A                                                                                                 GTPBP4 p53 con&#239;&#172;?rmed various conditions. <br />                                                                                              WB: <br />  <br />  <br />  <br />  <br />                                                                                      3 <br />                                                                                       3 <br />                                                                                       3 <br />                  3 <br />                  3 <br />                  3 <br />  <br />  <br />                              3 <br />                              3 <br />                              3 <br />  <br />  <br />                                           3 <br />                                           3 <br />                                           3 <br />  <br />  <br />                                                       3 <br />                                                       3 <br />                                                       3 <br />  <br />  <br />                                                                3 <br />                                                                 3 <br />                                                                 3 <br />  <br />  <br />                                                                           3 <br />                                                                            3 <br />                                                                            3 <br />  <br />                                                                                 p5 <br />                                                                                    p6 <br />                                                                                    p7 <br />               p5 <br />               p6 <br />               p7 <br />  <br />  <br />                           p5 <br />                           p6 <br />                           p7 <br />  <br />  <br />                                        p5 <br />                                        p6 <br />                                        p7 <br />  <br />  <br />                                                    p5 <br />                                                    p6 <br />                                                    p7 <br />  <br />  <br />                                                            p5 <br />                                                              p6 <br />                                                              p7 <br />  <br />  <br />                                                                        p5 <br />                                                                         p6 <br />                                                                         p7 <br />    Co-AP                                                                                           Endogenous GTPBP4 copuri&#239;&#172;?ed MBP-p53 transfected <br />                                                                                              tag   U2OS cells (Fig. 4A), endogenous GTPBP4 coimmuno- <br />      input <br />                                                                                                    precipitated endogenous p53 HCT116 WT cells treated <br />       AP                                                                                     MBP   Nutlin-3 (Fig. 4B). Using puri&#239;&#172;?ed proteins, that <br />                                                                                                    GTPBP4 bind p53 vitro (Fig. S5). To evaluate possible <br />                                                                                                    role cancer, analyzed public datasets determine GTPBP4 <br />         Gene              prey construct                          MBP baits                        predictive value terms survival. Using Cox uni- <br />  B                                                                                                 variate analysis, increased GTPBP4 expression <br />                                                        p53         TAp63&#206;&#177;       TAp73&#206;&#177; <br />                                                                                                    correlates reduced patient survival large breast cancer <br />            HSF1                MYC-HSF1 <br />            LHX2        (mouse) HA-LHX2                                                             datasets: NKI (P = 0.00025), Pawitan (P = 0.00024), Miller <br />            PAX6                MYC-PAX6                                                            (P = 0.0015) (28&#226;&#8364;&#8220;30). In Miller study, status p53 is <br />           ASF1a                 HA-ASF1a <br />           BRD8                   HA-BRD8                                                           known sample, GTPBP4 levels correlate <br />        SMARCD2                 HA-BAF60B <br />          DNAJB6               HA-DNAJB6                                                            negatively survival tumors wild-type p53 (Fig. 4C). <br />           AKAP1 (mouse) FLAG-AKAP1b                                                                   To de&#239;&#172;?ne functional link GTPBP4 p53, we <br />           DDX23                 HA-DDX23 <br />         IGF2BP1                 GFP-IMP1                                                           analyzed cell cycle pro&#239;&#172;?le cells transfected GTPBP4 <br />         LRPPRC              GFP-LRPPRC                                                             siRNA, drug treatment. As shown Fig. 4, <br />         MTHFSD               HA-MTHFSD <br />          EIF2C1                  HA-AGO1                                                           depletion GTPBP4 inhibited cell proliferation, causing marked <br />          EIF2C2                  HA-AGO2 <br />           PIWIL1                HA-PIWIL1                                                          p53-dependent reduction S-phase fraction. This result <br />            CDT1                  HA-CDT1                                                           apparently contradicts WST experiments indicating ef&#239;&#172;?cient <br />           STAG1                   HA-SA1 <br />           ASPM     (rat) GFP-ASPM(CH) <br />                                                                                                    arrest GTPBP4 knockdown cells (see Fig. 3B), be <br />         CLASP1              GFP-CLASP1                                                             explained considering cells depleted GTPBP4 tend arrest <br />           SASS6                 GFP-SAS6 <br />           MYL9                   HA-MYL9                                                           absence drug treatment. Under conditions, p53 <br />           TPM3        (mouse) HA-TPM3                                                              activation does induce signi&#239;&#172;?cant drop cell pro- <br />           ADH5                   HA-ADH5 <br />           AHCY                   HA-AHCY                                                           liferation. This phenomenon speci&#239;&#172;?c GTPBP4, because <br />           DPH1 <br />          INPP5E <br />                                  HA-DPH1 <br />                     (mouse) HA-INPP5E <br />                                                                                                    FACS analysis consistent WST results func- <br />         TRMT11                HA-TRMT11                                                            tional hits (Fig. S4). Immunoblotting revealed silencing of <br />           TTLL5              FLAG-TTLL5 <br />           AGBL2                 HA-AGBL2 <br />                                                                                                    GTPBP4 induces marked increase p53 levels accumulation <br />          DAB2IP          (rat) HA-DAB2IP                                                           p53 target p21Waf1 (Fig. 4F). GTPBP4 depletion caused <br />           GAS8        (mouse) HA-GAS8 <br />         GTPBP4                HA-GTPBP4                                                            p53 accumulation cell lines, effect cell-context <br />            JPH1  (rabbit) GFP-JP1(FP3) <br />           N4BP2                 HA-N4BP2                                                           speci&#239;&#172;?c (Fig. S5). To test p53 transcriptionally active, we <br />           RNF38                 HA-RNF38                                                           analyzed selected p53-target genes RT-qPCR, revealing in- <br />           SART1               YFP-SART1 <br />           SPSB1                 HA-SPSB1                                                           creased mRNA levels p21, Hdm2, Puma (Fig. 4G). <br />          C4orf41               HA-C4orf41                                                             Because nucleolar stress induces p53 stabilization activation <br />         C6orf165             HA-C6orf165 <br />         C16orf35             HA-C16orf35                                                           (31, 32), asked GTPBP4 knockdown cause nucleolar <br />         C22orf28             HA-C22orf28 <br />                                                                                                    dysfunction. We used RT-qPCR analyze transcription rRNA <br />                                 Signal equal greater 1/40 input                     signi&#239;&#172;?cant alterations pre-rRNA levels (Fig. 4I). <br />                                 Signal lower 1/40 input                                We used immuno&#239;&#172;&#8218;uorescence study nucleolar markers; local- <br />                                 Very weak signal <br />                                 Signal stronger MBP control, signal                 ization Nucleolin UBF (Fig. 4H), B23/Nucleo- <br />                                                                                                    phosmin Fibrillarin (Fig. S5), affected. On the <br />  C                                                                                                 contrary, treatment actinomycin D altered localization all <br />                      p63 (24)               p53                                                    markers analyzed, including GTPBP4 (Fig. 4H). These data indi- <br />                                            (207)                                     p63 (5)       cate GTPBP4 knockdown does disrupt nucleolar struc- <br />       p53                                                                            2             ture. However, ribosomal stress cause p53 stabilization in <br />              1                  5                                                  1 2 <br />                      19                                         197                                absence evident nucleolar alteration (33). We therefore <br />       (24)                                                                     9     4 <br />                  4                                                                                 measured p53 half-life GTPBP4 knockdown HCT116 WT <br />                             8 <br />                                                                                       p73 <br />                                     p73                                               (16)         cells; notably, stabilization detected (Fig. S5). Moreover, <br />                                     (36)                                                           GTPBP4 depletion did impair p53 accumulation DNA <br />                                                                                                    damage (Fig. S5), con&#239;&#172;?rming p53 stabilized in <br />                  This study                                  BioGrid <br />                                                                                                    response speci&#239;&#172;?c signals. Together, data indicate tran- <br />                                                                                                    sient GTPBP4 knockdown does disrupt nucleolar structure or <br /> Fig. 2. Binding human orthologs Dmp53 interactors p53 p53-                            function, suggesting direct effect regulating p53 levels. <br /> related proteins. (A) Seven representative co-AP experiments. Shown are <br /> examples preys interacted p53-family proteins                               Discussion <br /> (TRMT11), preys bound selected members p53 family (ASF1A,                           Taking advantage small size &#239;&#172;&#8218;y proteome, studied <br /> GAS8, GTPBP4, C22orf28), preys scored interacting <br />                                                                                                    protein interaction pro&#239;&#172;?le Drosophila p53 IVEC. This <br /> (LHX2 SART1). (Top) Tagged prey proteins coaf&#239;&#172;?nity puri&#239;&#172;?cation. <br /> (Middle) Expression prey total lysates (1/40th input). (Bottom) <br />                                                                                                    approach identi&#239;&#172;?ed potential interactions escaped <br /> MBP-tagged baits af&#239;&#172;?nity puri&#239;&#172;?cation. The Top Middle crop-                           detection previous studies, including high-throughput whole- <br /> ped autoradiography (i.e., exposure). (B) Table                        genome yeast-two-hybrid screens (34, 35). This result suggests that <br /> summarizing results co-AP assays 41 mammalian orthologs                              current protein interaction databases probably far satu- <br /> Dmp53 interacting proteins. Expression plasmids encoding indicated                             ration exhaustive protein interaction maps gen- <br /> tagged proteins cotransfected pcDNA3-MBP, pcDNA3-MBP-p53, <br /> pcDNA3-MBP-TAp63&#206;&#177;, pcDNA3-MBP-TAp73&#206;&#177; 293T cells. MBP fusion <br /> proteins (baits) puri&#239;&#172;?ed amylose beads, copuri&#239;&#172;?ed proteins <br /> were detected immunoblotting. Strength interaction scored                                p53 family members mammals. The results study compared to <br /> according fraction input prey protein copuri&#239;&#172;?ed MBP                        current data available protein&#226;&#8364;&#8220;protein interaction databases (BioGrid <br /> baits. (C ) Venn diagrams summarizing protein interactions associated                         release 2.0.45). <br />  <br />  <br />  <br /> 6324 | www.pnas.org/cgi/doi/10.1073/pnas.1002447107                                                                                                            Lunardi et al. <br />                                                                                                       erated combining multiple experimental approaches. GO <br /> A <br />  <br />  <br />  <br />  <br />                                                  el t, <br />                                               -w un <br />                                                                                                      term analysis vitro Dmp53 interactome revealed enrich- <br />  <br />  <br />  <br />  <br />                                                   n <br />  <br />  <br />  <br />  <br />                                                    l <br />                                           96 co <br />                                                  n <br />  <br />  <br />                                                 io <br />                                                io <br />  <br />                                         ns A <br />                                       ns A <br />                                                                                                      ment genes involved gametogenesis. Because p53 mutant &#239;&#172;&#8218;ies <br />  <br />  <br />  <br />  <br />                                              ct <br />  <br />  <br />                                        , <br />                                     tra N <br />                                             ct <br />  <br />  <br />  <br />  <br />                                     e ze <br />                                    tra iRN <br />  <br />  <br />  <br />  <br />                                            fe <br />                                   d siR <br />                                           fe <br />  <br />  <br />  <br />  <br />                                           s <br />                                   ni <br />  <br />  <br />  <br />  <br />                                        ug <br />                                         s <br />  <br />  <br />  <br />  <br />                                 pl psi <br />                                                                                                      accumulate aberrant number primordial germ cells ectopic to <br />  <br />  <br />  <br />  <br />                                     dr <br />                                   try <br />  <br />  <br />  <br />  <br />                                   d <br />                               t <br />                                                                                                      gonads (36), p53 p63 involved genoprotective <br />  <br />  <br />  <br />                                2n <br />  <br />  <br />  <br />  <br />                                ad <br />                            1s <br />                                                                                          WST-1 <br />                          48h      24h         6h                    12h        48h       assay       apoptotic responses mammalian gametogenesis (9, 37, 38), <br />                                                                                                      novel interactors help dissect functional role p53 <br /> B                HCT116 p53+/+                HCT116 p53-/-                                          family. Another notable feature vitro Dmp53 interactome <br />                                                                                                      high representation cytoplasmic mitochondrial pro- <br />            100 <br />                            **       **                                                           C   teins. Mammalian p53 important transcription-independent <br />             80 <br />     WST <br />  <br />  <br />  <br />  <br />                                                                           siCTRL <br />                                                                           siASPM                     function mitochondria (39, 40); results suggest this <br />             60 <br />                                                                                                      function evolutionarily ancient, shall look for <br />             40 <br />                                                                                                      mitochondrial activities p53 family paralogs. <br />            100                                                                                   D      We tested binding mammalian orthologs Dmp53 inter- <br />                            **         * <br />             80                                                                                       actors p53, p63, p73. Notably, 90% bound more <br />     WST <br />  <br />  <br />  <br />  <br />                                                                           siCTRL <br />             60                                                            siMYL9                     p53-family members coaf&#239;&#172;?nity puri&#239;&#172;?cation experiments, sug- <br />             40                                                                                       gesting interactions evolutionarily conserved. <br />                                                                                                      Surprisingly, orthologs vitro Dmp53 interactors bound <br />            100 <br />                            **         *                                                       E      ef&#239;&#172;?ciently TAp73&#206;&#177;. If con&#239;&#172;?rmed, data pro- <br />             80 <br />     WST <br />  <br />  <br />  <br />  <br />                                                                           siCTRL <br />                                                                           siDAB2IP <br />                                                                                                      vocative implications p53 phylogenesis (6, 12, 15). <br />             60 <br />                                                                                                         We functionally validated potential p53 interactors using RNAi. <br />             40 <br />                                                                                                      Of &#239;&#172;?ve genes knockdown affected p53 response, we <br />            100                                                                                   F   focused nucleolar protein GTPBP4. We GTPBP4 <br />                            **       ** <br />             80                                                                                       knockdown induces accumulation p53, resulting reduced cell <br />     WST <br />  <br />  <br />  <br />  <br />                                                                           siCTRL <br />             60                                                            siGTPBP4                   proliferation. Because GTPBP4/Nog1 essential biogenesis of <br />             40                                                                                       60S ribosomal subunit (25&#226;&#8364;&#8220;27), exclude p53 <br />                                                                                                      accumulation GTPBP4 siRNA indirect consequence of <br />            100 <br />                           **          **                                                         G   defect ribosome biogenesis triggering stress pathway (31, 41, <br />             80                                                            siCTRL                     42). However, provide evidence nucleolar structure and <br />     WST <br />  <br />  <br />  <br />  <br />                                                                           siSPSB1 <br />             60                                                                                       function altered GTPBP4 depletion, time <br />             40                                                                                       frame experiments. Importantly, &#239;&#172;?nd p53 half-life is <br />                  -                            - <br />                                                                                                      increased cells, indirectly excluding ribosomal <br />     Nutlin                 5        15               5      15 <br />      (&#206;&#188;M)                                                                                            stress pathways act inhibition Mdm2 (31, 41, 42). A <br />                                                                                                      mechanistic understanding p53 activated GTPBP4 <br />                                                                                                      depletion require signi&#239;&#172;?cant additional work, have <br /> H                    GFP-ASPM(CH)                                             GFP-MYL9 <br />                                                                                                      relevant implications; fact, line observation high <br />           p53        +     -      +                          p53          +    -     +               GTPBP4 expression correlates reduced survival breast <br />                                            WB: p53                                       WB: p53     tumors, increased levels GTPBP4 contribute dampen <br />   IP: GFP                                                IP: GFP                                     p53 activities cancer cells. <br />                                            WB: GFP                                       WB: GFP <br />                                                                                                         In conclusion, starting vitro interaction screen with <br />                                                                                                      Drosophila proteins, uncovered evolutionarily conserved <br />                                            WB: p53                                       WB: p53 <br />     lysate                                                lysate                                     p53 interactor relevant cancer. This result <br />                                            WB: GFP                                       WB: GFP     supports potential impact approach. Despite large <br />                                                                                                      available knowledge, lack organic model of <br />                                                                                                      p53 network responds speci&#239;&#172;?c signals diverse cel- <br />                      GFP-DAB2IP                                               HA-SPSB1               lular contexts, p53-family proteins &#239;&#172;?ne tuned achieve <br />                           -                                  p53               -                     wide spectrum cellular responses, func- <br />           p53    +              +                                         +          + <br />                                                                                                      tionally integrated signaling pathways. Given the <br />                                            WB: p53                                        WB: p53    emerging importance p53 family members tumor sup- <br />   IP: GFP                                                 IP: HA <br />                                            WB: GFP                                        WB: HA <br />                                                                                                      pression, list evolutionarily conserved potential interactors <br />                                                                                                      constitute valuable platform gain additional insights <br />                                            WB: p53                                        WB: p53 <br />                                                                                                      mammalian p53 network. <br />     lysate                                                 lysate <br />                                            WB: GFP                                        WB: HA     Methods <br />                                                                                                                                                                                            CELL BIOLOGY <br />  <br />  <br />  <br />  <br />                                                                                                      Plasmids. Many expression vectors mammalian orthologs Dmp53 inter- <br /> Fig. 3. Functional validation p53 interactors RNAi. (A) Schematic dia-                         actors kindly provided investigators. Alternatively, full-length ESTs <br /> gram experimental procedure. p53-dependent growth inhibition                              purchased I.M.A.G.E. clone distributors; coding regions were <br /> assayed knockdown newly identi&#239;&#172;?ed potential p53 interactants. After                         ampli&#239;&#172;?ed PCR cloned frame HA tag modi&#239;&#172;?ed version the <br /> siRNA transfection, cells trypsinized counted, identical numbers                        pCS2 expression vector. More detailed information plasmids primers is <br /> of cells seeded 96-well plates. Drugs added 12 h later, WST-1                       available request. <br /> activity measured additional 48 h. (B) Transient knockdown of <br /> &#239;&#172;?ve putative p53 interactors affects response HCT116 WT cells Nutlin- <br /> 3. To control p53 dependency, experiment HCT116 p53&#226;&#710;&#8217;/ <br /> &#226;&#710;&#8217; <br />   cells (*, P &lt; 0.05; **, P &lt; 0.01; n = 3). (C&#226;&#8364;&#8220;G) Cellular localization functionally              functionally validated interactors. Expression plasmids encoding indicated <br /> validated p53 interactors. C shows localization endogenous ASPM                              proteins cotransfected p53-null H1299 cells. After cell lysis, tagged <br /> mitotic U2OS cell, Hoechst counterstaining metaphase chromosomes.                           proteins immunoprecipitated using antibodies cross-linked protein G <br /> D&#226;&#8364;&#8220;G immuno&#239;&#172;&#8218;uorescence indicated HA-tagged proteins tran-                                 beads analyzed immunoblotting. Expression transfected proteins in <br /> siently transfected U2OS cells. (H) Coimmunoprecipitation p53                        lysate (1/40th input) shown Lower part. <br />  <br />  <br /> Lunardi et al.                                                                                                                  PNAS | April 6, 2010 | vol. 107 | no. 14 | 6325 <br />                                            A                                        B                                                                         C <br />  <br />  <br />  <br />  <br />                                                                  3 <br />                                                                p5 <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                1.0 <br />                                                                                                                              /+ <br />                                                                                                                /- <br />  <br />  <br />                                                                                                                          3+ <br />                                                            - <br />  <br />  <br />  <br />  <br />                                                                                                            3- <br />                                                          BP <br />  <br />                                                         BP <br />                                                                                                                                                                                                                                                                                  low <br />  <br />  <br />  <br />  <br />                                                                                                           p5 <br />  <br />  <br />                                                                                                                         p5 <br />                                                        M <br />  <br />                                                        M <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                0.8 <br />                                           co-AP                                    Nutlin-3               -         -        +                                                                                                                                                   high <br />  <br />  <br />  <br />  <br />                                                                                                                                                                  Probability <br />                                                                   GTPBP4 <br />                                            input <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                0.6 <br />                                                                                                                                    GTPBP4 <br />                                                                                    IP: p53 <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                0.4 <br />                                                                                                                                    p53 <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                0.2 <br />                                               AP                  MBP <br />                                                                                                                                    GTPBP4 <br />                                                                                      input                                                                                                                                                                         P &lt; 0.02 <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                0.0 <br />                                                                                                                                    p53                                               0                                  2                        4         6           8    10 <br />                                                                                                                                                                                                                                              Survival (years) <br />  <br />  <br />      D                                      siCTRL             siGTPBP4                E                            siCTRL <br />                                                                                                                     siGTPBP4 <br />                                                                                                                                                     F                                               NT                                                   Nutlin-3                Doxo <br />                                                                                                      50                                                   Mock                 +                                                                     +                      + <br />                                              subG1: 4.0            subG1: 10.9                                           S phase <br />                                                                                                      40                                                 siCTRL                                                   +                                             +                   + <br />                    number cells <br />  <br />  <br />  <br />  <br />                                                 G1: 27.6              G1: 44.4 <br />                                                                                                                                                                                                                                              +                         +                    + <br />         HCT116 <br />         p53 +/+ <br />  <br />  <br />  <br />  <br />                                                                                                                                          p53 +/+ <br />                                                  S: 44.6               S: 21.2                                                                       siGTPBP4 <br />  <br />  <br />                                                                                          cells (%) <br />                                                                                                      30 <br />                                                 G2: 20.1              G2: 21.0 <br />                                                                                                      20                                                                                                                                                                                          GTPBP4 <br />                                                                                                      10 <br />                                                                                                                                                                                                                                                                                                  p53 <br />                                                                                                      0 <br />                                                                                                      60                                                                                                                                                                                          p21 <br />                                               subG1: 5.7        subG1:      11.7                                         S phase <br />                                                                                                      50 <br />                                                  G1: 35.3          G1:      31.8 <br />         HCT116 <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                                                  HSP90 <br />          p53 -/- <br />  <br />  <br />  <br />  <br />                                                                                                                                          p53 -/- <br />                                                   S: 39.4           S:      38.5                     40 <br />                                                                                          cells (%) <br />                        number cells <br />  <br />  <br />  <br />  <br />                                                  G2: 19.4          G2:      15.6                     30 <br />                                                                                                      20 <br />                                                                                                                                                                                G                                 4                                                                      * <br />                                                                                                      10                                                                                                                                                                * <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                          normalized expression <br />                                                                                                       0 <br />                                                                                                                                                                                                                  3 <br />                                          DNA content (PI)      DNA content (PI) <br />                                                                                                                -    Nut          Doxo                                                                                                                      * <br />                                                                                                                                                                                                                                                                                                 siCTRL <br />                                                                                                                                                                                                                  2 <br />                                                                                                                                                                                                                                                                                                 siGTPBP4 <br />      H                                    GTPBP4            Hoechst         nucleolin                 Hoechst                      UBF             Hoechst <br />                                                                                                                                                                                                                  1 <br />                                                                                                                                                                                                                                                  * <br />                                                                                                                                                                                                                  0 <br />       siGTPBP4 <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                                       4 <br />  <br />                                                                                                                                                                                                                                                          1 <br />  <br />                                                                                                                                                                                                                                                                     2 <br />  <br />                                                                                                                                                                                                                                                                             X <br />  <br />                                                                                                                                                                                                                                                                                       A <br />                                                                                                                                                                                                                     BP <br />  <br />  <br />                                                                                                                                                                                                                                                      p2 <br />  <br />  <br />                                                                                                                                                                                                                                                                    M <br />  <br />                                                                                                                                                                                                                                                                            BA <br />  <br />  <br />                                                                                                                                                                                                                                                                                   M <br />                                                                                                                                                                                                                                                                D <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                                  PU <br />                                                                                                                                                                                                                   TP <br />  <br />  <br />  <br />  <br />                                                                                                                                                                                                                                                                H <br />                                                                                                                                                                                                                  G <br />                                                                                                                                                                                      I                                                        1.2                  rRNA <br />  <br />                                                                                                                                                                                                                      normalized expression <br />           siCTRL                                                                                                                                                                                                                              1.0 <br />                                                                                                                                                                                                                                               0.8 <br />                                                                                                                                                                                                                                               0.6 <br />                                                                                                                                                                                                                                               0.4 <br />  <br />               ActD                                                                                                                                                                                                                            0.2 <br />                                                                                                                                                                                                                                               0.0 <br />                                                                                                                                                                                                                                                          siCTRL siGTPBP4 <br />  <br /> Fig. 4. Evidence functional link nucleolar protein GTPBP4 p53. (A) Exogenous p53 binds endogenous GTPBP4. Coaf&#239;&#172;?nity puri&#239;&#172;?- <br /> cation GTPBP4 overexpressed MBP-p53 U2OS cells shown. (Top) Endogenous GTPBP4 coaf&#239;&#172;?nity puri&#239;&#172;?cation. (Middle) Expression of <br /> GTPBP4 total lysates (1/40th input). (Bottom) MBP MBP-p53 proteins af&#239;&#172;?nity puri&#239;&#172;?cation. (B) Interaction endogenous GTPBP4 <br /> and p53. Coimmunoprecipitation shown GTPBP4 p53 HCT116 WT cells untreated treated 12 h 5 &#206;&#188;M Nutlin-3. (Upper) Proteins <br /> immunoprecipitated using anti-p53 monoclonal antibody (DO-1). (Lower) Endogenous p53 GTPBP4 proteins lysates (1/40th input). As <br /> negative control, immunoprecipitation performed HCT116 p53&#226;&#710;&#8217;/&#226;&#710;&#8217; cells. (C ) Cumulative survival (Kaplan&#226;&#8364;&#8220;Meier) curves showing higher <br /> expression GTPBP4 correlates reduced survival breast cancer bearing wild-type p53 (30). Probesets corresponding GTPBP4 averaged and <br /> divided low expressers (88 samples) high expressers (93 samples), using median GTPBP4 expression cutoff. The groups display a <br /> signi&#239;&#172;?cant difference survival rates (P = 0.0193). (D) Transient knockdown GTPBP4 induces p53-dependent inhibition cell proliferation. FACS <br /> analysis shown HCT116 WT HCT116 p53&#226;&#710;&#8217;/&#226;&#710;&#8217; cells transfected control GTPBP4 siRNA. (E) Knockdown GTPBP4 reduces S-phase cells <br /> bearing p53. Average S-phase fraction shown HCT116 WT HCT116 p53&#226;&#710;&#8217;/&#226;&#710;&#8217; cells transfected control GTPBP4 siRNA treated 24 h <br /> with 5 &#206;&#188;M Nutlin-3 0.05 &#206;&#188;M Doxorubicin. Values means &#194;&#177; SD (n = 3). (F ) Knockdown GTPBP4 induces accumulation p53 p21 proteins. <br /> Immunoblotting shown HCT116 WT cells transfected control GTPBP4 siRNA left untreated (NT) treated 24 h Nutlin-3 (5 &#206;&#188;M) or <br /> Doxorubicin (0.05 &#206;&#188;M). A speci&#239;&#172;?c antibody GTPBP4 con&#239;&#172;?rmed ef&#239;&#172;?cient knockdown endogenous protein. Hsp90 detected lysates <br /> as loading control. (G) Knockdown GTPBP4 promotes transcription p53-target genes. RT-qPCR shows up-regulation p53-target genes HCT116 <br /> WT cells transfected 48 h GTPBP4 siRNA. mRNA expression normalized GAPDH. Analysis GTPBP4 mRNA samples con&#239;&#172;?rms the <br /> ef&#239;&#172;?ciency knockdown (*, P &lt; 0.05; n = 3). (H) GTPBP4 knockdown does affect localization key nucleolar proteins. Immuno&#239;&#172;&#8218;uorescence analysis is <br /> shown GTPBP4, Nucleolin, UBF U2OS cells transfected 48 h control GTPBP4 siRNA. The proteins analyzed U2OS <br /> cells treated 5 nM Actinomycin D 12 h. Nuclei counterstained Hoechst. (I) GTPBP4 knockdown does affect rRNA transcription. HCT116 <br /> WT cells transfected control GTPBP4 siRNA, prerRNA levels quanti&#239;&#172;?ed RT-qPCR 48 h, using primers speci&#239;&#172;?c 5&#226;&#8364;&#178; <br /> external transcribed spacer pre-rRNA normalizing GAPDH. Values means &#194;&#177; SD. <br />  <br />  <br /> Antibodies, Immunoblotting, Immuno&#239;&#172;&#8218;uorescence. For immunoblotting                                                                          X-100. Proteins visualized directly GFP-tagged clones using speci&#239;&#172;?c <br /> experiments, HCT116 cells lysed RIPA buffer [150 mM NaCl, 50 mM Tris&#194;&#183;HCl                                                               antibodies. Images captured using Leica DM4000B epi&#239;&#172;&#8218;uorescence <br /> (pH8), 1 mM EDTA, 1% Nonidet P-40, 0.5% Na-deoxycholate] proteases                                                                        microscope. Antibodies used mouse anti-Flag (M2; Sigma), mouse anti-Myc <br /> inhibitors. Protein concentration measured Bradford assay (Bio-Rad).                                                                    (9E10), mouse anti-HA (12CA5), mouse anti-HSP90 (Santa Cruz), mouse anti-p53 <br /> Lysates resolved SDS/PAGE transferred nitrocellulose (Millipore).                                                               (DO-1; Santa Cruz), mouse anti-p21 (Santa Cruz), mouse anti-UBF1 (F-9; Santa <br /> Antibodies detected chemiluminescence (ECL; GE Healthcare). For                                                                        Cruz), mouse anti-Nucleolin (Zymed), goat anti-GST (GE Healthcare), rabbit anti- <br /> immuno&#239;&#172;&#8218;uorescence, cells &#239;&#172;?xed 24 h posttransfection 4% parafor-                                                                        GFP (self-produced), rabbit anti-MBP (self-produced), rabbit anti-GTPBP4 <br /> maldehyde room temperature, permeabilized PBS plus 0.1% Triton                                                                       (Proteintech). <br />  <br />  <br /> 6326 | www.pnas.org/cgi/doi/10.1073/pnas.1002447107                                                                                                                                                                                                                                                Lunardi et al. <br />  Coaf&#239;&#172;?nity Puri&#239;&#172;?cations. Co-AP experiments performed described (43),                          adherent &#239;&#172;&#8218;oating cells collected &#239;&#172;?xed ethanol. After rehy- <br /> with minor changes. Plasmids transfected human 293T cells. Forty-eight                       dration, cells treated 200 &#206;&#188;g/mL RNAseA 40 &#206;&#188;g/mL propidium <br /> hours transfection cells lysed coaf&#239;&#172;?nity puri&#239;&#172;?cation buffer [50 mM                     iodide analyzed &#239;&#172;&#8218;ow cytometer (FacsCalibur; BD). FACS data were <br /> Tris&#194;&#183;HCl (pH 8), 150 mM NaCl, 1 mM EDTA (pH 8), 1 mM DTT, 5% glycerol, pro-                          processed using FlowJo software, cell cycle pro&#239;&#172;?les determined <br /> tease inhibitors (Sigma), 1 mM PMSF, 5 mM NaF, 1 mM beta-glycerolphosphate]                          using Watson pragmatic model (Tree Star). <br /> for 30 min ice cleared centrifugation 30 min 13,000 &#195;&#8212; g 4 &#194;&#176;C,                       Additional methods provided SI Methods. <br /> and protein complexes collected amylose beads. After extensive <br /> washes, puri&#239;&#172;?ed complexes separated SDS/PAGE, detected immu-                              ACKNOWLEDGMENTS. We thank L. Carlsson, C. Y. Choi, R. Crosbie, G. Denis, <br /> noblotting, visualized ECL. Puri&#239;&#172;?ed MBP baits visualized DAB                          A. Dutta, T. Fujita, N. Galjart, P. Gonczy, T. Hollenberger, W. G. Kaelin, Jr., A. <br /> staining (Sigma).                                                                                    I. Lamond, S. Lin-Chao, L. Liu, J. Loturco, C. Mitchell, R. I. Morimoto, F. Cilius <br />                                                                                                      Nielsen, S. Ove Boe, J.-M. Peters, H. Takeshima, S. Taylor, S. Rosenbaum, R. <br /> Cell Viability Proliferation Assays. A custom library containing siRNAs                    Samant, S. Stoney-Simons, Jr., N. Watanabe, D. Wieczorek providing <br /> (Ambion Silencer) p53 interactor purchased Applied Bio-                            expression plasmids mammalian proteins used work. <br /> systems. For viability assays, HCT116 colon cancer cells plated low                          We thank Stefano Gustincich members lab sharing reagents <br />                                                                                                      equipment. We acknowledge important contribution Fabio Fais <br /> density six-well plates. Thirty-six hours postseeding, cells transfected <br />                                                                                                      Stefania Luppi, helped IVEC screening. This work was <br /> with siRNA pools (60 nM) using RNAiMAX reagent (Invitrogen). A second round                          supported grants Italian Association Cancer Research, the <br /> of siRNA transfection performed 24 h later using Lipofectamine 2000                              Italian Ministry University Research, Regione Friuli Venezia <br /> (Invitrogen). After additional 6 h, cells detached, counted, dis-                        Giulia (LR26/2005) (to L.C.) grants Italian Association for <br /> pensed 96-well plates. Drugs added 12 h later, 48 h, cell                        Cancer Research, Italian Ministry University Research, European <br /> viability assayed using WST-1 reagent (Roche). For FACS analysis,                       Community FP6 contracts 503576 502983 (to G.D.S.). <br />  <br />  <br />  1. Vousden KH, Lu X (2002) Live let die: The cell&#226;&#8364;&#8482;s response p53. Nat Rev Cancer 2:594&#226;&#8364;&#8220;604.   24. Styhler S, Nakamura A, Lasko P (2002) VASA localization requires SPRY-domain <br />  2. Hainaut P, et al. (1997) Database p53 gene somatic mutations human tumors                      SOCS-box containing protein, GUSTAVUS. Dev Cell 3:865&#226;&#8364;&#8220;876. <br />     cell lines: Updated compilation future prospects. Nucleic Acids Res 25:151&#226;&#8364;&#8220;157.          25. Lapik YR, Misra JM, Lau LF, Pestov DG (2007) Restricting conformational &#239;&#172;&#8218;exibility of <br />  3. Mantovani F, et al. (2007) The prolyl isomerase Pin1 orchestrates p53 acetylation                switch II region creates dominant-inhibitory <span id='am-81' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-82' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-83' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-84' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-85' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-86' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-87' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-88' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-89' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-90' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-91' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-92' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-93' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-94' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-95' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-96' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-97' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-98' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-99' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-100' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-101' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-102' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-103' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-104' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-105' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-106' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-107' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-108' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-109' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-110' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-111' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-112' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-113' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-114' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-115' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-116' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-117' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-118' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-119' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-120' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-121' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-122' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-123' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-124' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-125' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-126' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-127' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-128' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-129' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-130' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-131' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-132' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-133' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-134' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-135' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-136' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-137' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-138' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-139' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-140' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-141' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-142' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-143' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-144' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-145' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-146' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-147' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-148' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-149' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-150' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-151' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-152' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-153' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-154' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-155' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-156' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-157' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-158' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span>phenotype</span> Obg GTPase Nog1. <br />     dissociation apoptosis inhibitor iASPP. Nat Struct Mol Biol 14:912&#226;&#8364;&#8220;920.                     Mol Cell Biol 27:7735&#226;&#8364;&#8220;7744. <br />  4. Marchenko ND, Wolff S, Erster S, Becker K, Moll UM (2007) Monoubiquitylation                     26. Jensen BC, Wang Q, Kifer CT, Parsons M (2003) The NOG1 GTP-binding protein is <br />     promotes mitochondrial p53 translocation. EMBO J 26:923&#226;&#8364;&#8220;934.                                         required biogenesis 60S ribosomal subunit. J Biol Chem 278:32204&#226;&#8364;&#8220;32211. <br />  5. Kruse J-P, Gu W (2009) Modes p53 regulation. Cell 137:609&#226;&#8364;&#8220;622.                                27. Fuentes JL, Datta K, Sullivan SM, Walker A, Maddock JR (2007) In vivo functional <br />  6. Yang A, Kaghad M, Caput D, McKeon F (2002) On shoulders giants: p63, p73                      characterization Saccharomyces cerevisiae 60S biogenesis GTPase Nog1. Mol <br />     rise p53. Trends Genet 18:90&#226;&#8364;&#8220;95.                                                          Genet Genomics 278:105&#226;&#8364;&#8220;123. <br />  7. Stiewe T (2007) The p53 family differentiation tumorigenesis. Nat Rev Cancer 7:           28. van Vijver MJ, et al. (2002) A gene-expression signature predictor survival in <br />     165&#226;&#8364;&#8220;168.                                                                                             breast cancer. N Engl J Med 347:1999&#226;&#8364;&#8220;2009. <br />  8. Flores ER, et al. (2005) Tumor predisposition mice mutant p63 p73: Evidence           29. Pawitan Y, et al. (2005) Gene expression pro&#239;&#172;?ling spares early breast cancer patients <br />     broader tumor suppressor functions p53 family. Cancer Cell 7:363&#226;&#8364;&#8220;373.                    adjuvant therapy: Derived validated population-based cohorts. <br />  9. Suh EK, et al. (2006) p63 protects female germ line meioti <br /> </body></html>